Indeed, a series of mouse studies have demonstrated that MYCN can be an oncogenic driver for glioma, medulloblastoma, primitive neuroectoderm tumor, and neuroblastoma (9, 10, 56). The gene discussed is MYCN; the disease is medulloblastoma.